DK1660135T3 - Fremgangsm de til at behandle hepatocellul re carcinomer - Google Patents

Fremgangsm de til at behandle hepatocellul re carcinomer

Info

Publication number
DK1660135T3
DK1660135T3 DK04777732T DK04777732T DK1660135T3 DK 1660135 T3 DK1660135 T3 DK 1660135T3 DK 04777732 T DK04777732 T DK 04777732T DK 04777732 T DK04777732 T DK 04777732T DK 1660135 T3 DK1660135 T3 DK 1660135T3
Authority
DK
Denmark
Prior art keywords
zvegf3
treating hepatocellular
procedures
mammal
hepatocellular carcinomas
Prior art date
Application number
DK04777732T
Other languages
Danish (da)
English (en)
Inventor
Thomas E Palmer
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK1660135T3 publication Critical patent/DK1660135T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK04777732T 2003-07-25 2004-07-09 Fremgangsm de til at behandle hepatocellul re carcinomer DK1660135T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49004703P 2003-07-25 2003-07-25
PCT/US2004/021835 WO2005011742A1 (en) 2003-07-25 2004-07-09 Method of treating hepatocellular carcinoma

Publications (1)

Publication Number Publication Date
DK1660135T3 true DK1660135T3 (da) 2009-09-07

Family

ID=34115347

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04777732T DK1660135T3 (da) 2003-07-25 2004-07-09 Fremgangsm de til at behandle hepatocellul re carcinomer

Country Status (9)

Country Link
US (4) US20050191304A1 (es)
EP (1) EP1660135B1 (es)
JP (1) JP4709145B2 (es)
AT (1) ATE432716T1 (es)
CA (1) CA2529798C (es)
DE (1) DE602004021395D1 (es)
DK (1) DK1660135T3 (es)
ES (1) ES2326978T3 (es)
WO (1) WO2005011742A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6893637B1 (en) * 1999-10-21 2005-05-17 Zymogenetics, Inc. Method of treating fibrosis
CA2871528A1 (en) 2012-04-24 2013-10-31 Thrombogenics N.V. Anti-pdgf-c antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2354325C (en) * 1998-12-07 2011-08-16 Zymogenetics, Inc. Growth factor homolog zvegf3
US6432673B1 (en) * 1998-12-07 2002-08-13 Zymogenetics, Inc. Growth factor homolog ZVEGF3
US6893637B1 (en) * 1999-10-21 2005-05-17 Zymogenetics, Inc. Method of treating fibrosis

Also Published As

Publication number Publication date
EP1660135A1 (en) 2006-05-31
CA2529798C (en) 2014-09-16
US20070054858A1 (en) 2007-03-08
US20110052588A1 (en) 2011-03-03
ES2326978T3 (es) 2009-10-22
WO2005011742A1 (en) 2005-02-10
EP1660135B1 (en) 2009-06-03
JP2006528663A (ja) 2006-12-21
CA2529798A1 (en) 2005-02-10
US20090028865A1 (en) 2009-01-29
ATE432716T1 (de) 2009-06-15
JP4709145B2 (ja) 2011-06-22
DE602004021395D1 (de) 2009-07-16
US20050191304A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
BRPI0510170B8 (pt) composto, composição farmacêutica para o tratamento de doenças mediadas pelo receptor muscarínico de acetilcolina e uso do composto
WO2008154638A3 (en) Antagonists of the receptor for advanced glycation end-products (rage)
CL2011001863A1 (es) Compuestos derivados de fenilaminopirimidinas, inhibidores de quinasa del linfoma anaplastico; composicion farmaceutica; combinacion farmacologica; y su uso en el tratamiento de trastornos proliferativos tales como linfoma, osteosarcoma, melanoma o tumor de mama, renal y de prostata, entre otros (divisional solicitud 3552-07).
CL2007000161A1 (es) Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
WO2006010057A3 (en) Therapeutic peptides
DK1135153T3 (da) Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
WO2007048026A3 (en) Cgrp peptide antagonists and conjugates
MA32806B1 (fr) Thérapie de combinaison avec des peptides époxycétones
WO2005077981A3 (en) Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES
CL2008001813A1 (es) Compuestos derivados de quinolin-3-carbonitrilo sustituidos con piperazina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis, inflamacion, cancer entre otras (div. sol. 266-04).
WO2006074445A3 (en) Novel heteropyrrole analogs acting on cannabiniod receptors
ATE389404T1 (de) Kappa-opioid-rezeptor-liganden
BRPI0517425A (pt) composto ou um sal, solvato, enanciÈmero, diastereÈmero ou mistura de diastereÈmeros do mesmo, composição farmacêutica, uso de composto
MA29600B1 (fr) Utilisation de sanglifehrine dans le virus de l'hepatite c
WO2009082038A3 (en) Ampa receptor antagonists and zonisamide for epilepsy
WO2005055973A3 (de) Endoparasitizide mittel zur topischen applikation
ATE364595T1 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
WO2008054597A3 (en) Tyrosine phosphorylation sites
WO2008013954A3 (en) Tyrosine phosphorylation sites
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
WO2008013934A8 (en) Tyrosine phosphorylation sites
WO2005117871A3 (en) Pharmaceutical compositions for the treatment of pruritus
DE602005010844D1 (de) Pharmazeutische zusammensetzungen mit interferon-tau
DK1660135T3 (da) Fremgangsm de til at behandle hepatocellul re carcinomer